Unigef 250mg Tablet
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Unigef 250mg Tablet
Afrinib 250mg tablets treat advanced non-small cell lung cancer. This medication is for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should strictly follow your physician's instructions, continuing treatment as directed. Treatment length depends on individual response. Regular liver function tests may be recommended. Common side effects include nausea, dry skin, appetite loss, and diarrhea. Increased fluid intake may lessen side effects. Report any concerning or worsening side effects to your doctor immediately. Seek immediate medical attention for mouth sores, vision changes, or breathing difficulties. Women should utilize reliable contraception throughout treatment and for one month post-treatment to prevent pregnancy. Disclose all other medications you are currently using to your doctor.
Uses of Unigef 250mg Tablet
Lung cancer (excluding small cell)
Major Benefits of Unigef 250mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Unigef 250mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Unigef 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Unigef 250mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Unigef 250mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Unigef 250mg Tablet works:
Oncaspar 250mg tablets are a cancer treatment that inhibits the activity of a malfunctioning protein responsible for cancer cell proliferation, thus hindering or slowing cancerous growth.
SAFETY ADVICE
AlcoholUNSAFE
Combining Unigef 250mg Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Unigef 250mg Tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Taking Unigef 250mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Unigef 250mg Tablets.
KidneyCAUTION
Individuals with significant kidney impairment should exercise caution when using Unigef 250mg Tablets. Dosage modification of Unigef 250mg Tablets may be necessary. A physician's consultation is advised.
LiverSAFE IF PRESCRIBED
Patients with liver disease can likely use Unigef 250mg Tablets without safety concerns. Available evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Unigef 250mg Tablet :
Omit any missed Unigef 250mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Unigef 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
3,018 People bought this recently